Drones could quicken AED delivery during heart attacks

Survival rates for out-of-hospital cardiac arrest remain between 8 and 10 percent, even though automated external defibrillators (AEDs) have become commonplace in public spaces. But three researchers in Sweden have a new way to hasten defibrillation for those in need: bring the devices to those in need with drones.

Led by Andreas Claesson, RN, PhD, with the Karolinska Institutet in Stockholm, the team sent a GPS-enabled drone to a specific location where a previous cardiac arrest incident had occurred. They then compared the response times with that of the emergency medical services.

In all 18 flights, the drone reached the destination more quickly than the ambulance, averaging a reduction in travel time of 16.5 minutes.

"This is a really neat, innovative method to combat a problem that we have been struggling with for decades," said Michael Kurz, MD, an emergency medicine professor and American Heart Association volunteer. "It's the same reason we have public access to defibrillation. Airports, casinos, large public venues have AEDs on the wall because presumably it would take a while for EMS to get there. This is, like, public-access defibrillation on steroids, where we just bring the defibrillator to you."

The researchers described their findings related to drone delivery of AEDs in a letter in the Journal of the American Medical Association.

For more, follow the link to NPR’s story:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.